Hint mode is switched on Switch off

Dexcom, ordinary share
DXCM, US2521311074

Add a stock to WL
Choose all Reset all
Dexcom, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Dexcom, Inc. is a company that develops, manufactures and distributes continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California, United States.
  • Issuer
  • Full borrower / issuer name
    Dexcom, Inc.
  • Industry
    Medical Devices

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    DXCM
  • Placement
    14.04.2005
  • Lock up period
    180
  • Number of papers
    4,700,000
  • Volume of raised funds
    56.4 mln USD
  • Placement share
    18%
  • Final placement price
    12 USD
  • Price change since placement date
    528.08%
  • By capitalization
    302.24 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Related Stock indices

Indicators

News

09/06/2026 DexCom (NASDAQ:DXCM) Surges on Strong Clinical Data and Financial Outlook
08/06/2026 DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes
02/06/2026 TNDM Stock: What to Know About Tandem's 2026 Reset
27/05/2026 Dexcom: Submission Of Matters To A Vote Of Security Holders
14/05/2026 Dexcom: Regulation Fd Disclosure, Other Events
All organization news

Other stocks and deposit receipts

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.